Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Control Groups × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Metformin 13 Liraglutide 4 semaglutide 3 Exenatide 3 Diet, Mediterranean 3 Dexamethasone 3 Caloric Restriction 3 Ovidrel 2 Mindfulness-Based Stress Reduction 2 Hydrocortisone 2 Exercise 2 Electroacupuncture 2 Docosahexaenoic Acids 2 Diet 2 Cosyntropin 2 sibutramine 1 penclomedine 1 mirabegron 1 lime 1 licogliflozin 1 dapagliflozin 1 Utrogestan 1 Topiramate 1 Therapeutics 1 Testosterone 1 Surveys and Questionnaires 1 Standard of Care 1 Spironolactone 1 Sodium-Glucose Transporter 2 Inhibitors 1 Qsymia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01150539 2021-08-25

POLY

Pennington Biomedical Research Center

Phase NA Completed

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡